Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Tue, 14.11.2023       PNE AG

First Berlin Equity Research hat ein Research Update zu PNE AG (ISIN: DE000A0JBPG2) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 25,00 auf EUR 22,00. Zusammenfassung: PNE hat die Ergebnisse für das dritte Quartal veröffentlicht und eine Telefonkonferenz abge [ … ]
Mon, 13.11.2023       Schloss Wachenheim AG

First Berlin Equity Research has published a research update on Schloss Wachenheim AG (ISIN: DE0007229007). Analyst Simon Scholes reiterated his BUY rating and maintained his EUR 22.00 price target. Abstract: Sales rose by 4.7% to €102.7m in Q1 23/24 (FBe: €103.5m; Q1 22/23: €98.0m) as SWA implemented price increases to compensat [ … ]
Thu, 09.11.2023       Deutsche Rohstoff AG

First Berlin Equity Research has published a research update on Deutsche Rohstoff AG (ISIN: DE000A0XYG76). Analyst Simon Scholes reiterated his BUY rating and decreased the price target from EUR 50.00 to EUR 47.00. Abstract: New wells helped DRAG post record sales and EBITDA numbers in Q3/23. While we expect 2023 investment of €182m to exc [ … ]
Thu, 09.11.2023       Knaus Tabbert AG

First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 86,00. Zusammenfassung: Der Q3-Bericht entsprach unseren Prognosen und übertraf die Vorjahreszahlen bei weitem. Wie erwartet, gi [ … ]
Tue, 07.11.2023       Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG

First Berlin Equity Research has published a research update on Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG (ISIN: DE0008041005). Analyst Christian Orquera reiterated his BUY rating and maintained his EUR 1.80 price target. Abstract: DEWB has published its financial statement for H1/23. Overall results were roughly as expected.  [ … ]
Tue, 31.10.2023       PSI AG

First Berlin Equity Research has published a research update on PSI SE (ISIN: DE000A0Z1JH9). Analyst Simon Scholes reiterated his BUY rating and decreased the price target from EUR 32.00 to EUR 30.00. Abstract: PSI's order intake climbed 25.5% to €69m (Q3/22: €55m) in Q3/23 and was up 16.1% at €238m (9M/22: €205m) after nine [ … ]
Wed, 25.10.2023       Deutsche Rohstoff AG

First Berlin Equity Research has published a research update on Deutsche Rohstoff AG (ISIN: DE000A0XYG76). Analyst Simon Scholes reiterated his BUY rating and increased the price target from EUR 44.00 to EUR 50.00. Abstract: DRAG has raised base-case revenue and EBITDA guidance for 2023 by 20.6% and 16.7% respectively and for 2024 by 11.1% and  [ … ]
Mon, 23.10.2023       ad pepper media International N.V.

First Berlin Equity Research hat ein Research Update zu ad pepper media International N.V. (ISIN: NL0000238145) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 3,50 auf EUR 3,00. Zusammenfassung: ad pepper media (APM) hat vorläufige Zahlen für das dritte Quarta [ … ]
Thu, 19.10.2023       Sernova Corp

First Berlin Equity Research has initiated coverage on Sernova Corp (ISIN: CA81732W1041). Analyst Christian Orquera's rating is BUY with a price target of CAD3.80 (USD2.80; €2.60). Abstract: Sernova Corp (Sernova) is a Canadian, clinical-stage biotech company developing cell therapeutics towards 'functional cures' for chronic debilitating  [ … ]
Wed, 18.10.2023       MPH Health Care AG

First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 59,00 auf EUR 62,00. Zusammenfassung: Der Sechsmonatsbericht spiegelt die Kursentwicklung der beiden wichtigsten börsennotierten B [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 13.07.2025, Calendar Week 28, 194th day of the year, 171 days remaining until EoY.